Atanasio
Pandiella Alonso
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (13)
2022
-
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer
Cancer research, Vol. 82, Núm. 24, pp. 4670-4679
-
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
Molecular Cancer Research, Vol. 20, Núm. 7, pp. 1108-1121
2021
-
Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5096-5108
2019
-
TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
Cancer Letters, Vol. 453, pp. 34-44
2017
-
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer
Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019
-
Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity
Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651
2016
2014
-
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy
Journal of the National Cancer Institute, Vol. 106, Núm. 11
-
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
BMC Cancer, Vol. 14, Núm. 1
2013
-
A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers
Oncogene, Vol. 32, Núm. 11, pp. 1452-1459
-
ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor
International Journal of Cancer, Vol. 133, Núm. 1, pp. 235-246
2005
-
N-terminal cleavage of proTGFα occurs at the cell surface by a TACE-independent activity
Biochemical Journal, Vol. 389, Núm. 1, pp. 161-172
2003
-
Impaired trafficking and activation of tumor necrosis factor-α-converting enzyme in cell mutants defective in protein ectodomain shedding
Journal of Biological Chemistry, Vol. 278, Núm. 28, pp. 25933-25939